Researchers identified non-coding regions of the human genome that control the development and function of four brain cell types and mapped genetic risk variants for psychiatric diseases. They found that risk variants for Alzheimer’s disease were enriched in microglia-specific regulatory elements.
Researchers at University of California San Diego School of Medicine, as well as a diverse team of cardiologists and physicists, developed a machine learning algorithm to predict the life expectancy in heart failure patients.
UC San Diego researchers linked a gut bacteria toxin to worse clinical outcomes in patients with alcoholic liver disease, and discovered that treatment with bacteriophages clears the bacteria and eliminates the disease in mice.
National attention has been drawn to the plight of patients who have experienced the unintended side effects of prolonged ICU care such as memory loss and muscle weakness. Now, a research team led by UC San Diego have evaluated the employment impacts to ICU patients, with concerning findings.
UC San Diego Health hospitals in Hillcrest and La Jolla have received grades of ‘A’ for excellence in safety and quality for the Fall 2019 Leapfrog Hospital Safety Grade report.
Of the 3.5 million breast cancer survivors in the US, 1 in 5 will be diagnosed with a painful swelling condition called lymphedema, which can occur as a consequence of lymph nodes being removed. UC San Diego Health now offers a novel surgical procedure to help prevent this debilitating condition.
San Diego-based Predictive Science, Inc. this week released their first forecast for the 2019-2020 influenza season, which typically runs from November through March.
UC San Diego Health opens a new clinic in Eastlake that offers express care and imaging capabilities with primary care opening late 2019.
UC San Diego researchers are leading a collaborative effort to understand and develop methods to help rectify hidden biases in healthcare.
J. Silvio Gutkind elected to National Academy of Medicine for his contributions to the understanding of cancer signaling networks and pioneering the study of the PIK3CA-mTOR signaling circuitry in head and neck cancer.